These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21132558)

  • 21. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China.
    Li S; Wang M; Liu L; Chen G
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12965. PubMed ID: 30499193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and quality of life: Comparing results from utility instruments and Diabetes-39.
    Chen G; Iezzi A; McKie J; Khan MA; Richardson J
    Diabetes Res Clin Pract; 2015 Aug; 109(2):326-33. PubMed ID: 26013567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
    Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
    Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).
    Chen J; Wong CK; McGhee SM; Pang PK; Yu WC
    PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial.
    Raisch DW; Feeney P; Goff DC; Narayan KM; O'Connor PJ; Zhang P; Hire DG; Sullivan MD
    Cardiovasc Diabetol; 2012 Jul; 11():35. PubMed ID: 22515638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis.
    Barnett C; Bril V; Bayoumi AM
    Eur J Neurol; 2019 Mar; 26(3):452-459. PubMed ID: 30315714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
    Lamu AN; Olsen JA
    Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease.
    Monroy M; Ruiz MA; Rejas J; Soto J
    Health Qual Life Outcomes; 2018 Sep; 16(1):177. PubMed ID: 30200982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of the relationship between body mass index and EQ-5D health utilities in individuals with type 2 diabetes: evidence from the population-based KORA studies.
    Hunger M; Schunk M; Meisinger C; Peters A; Holle R
    J Diabetes Complications; 2012; 26(5):413-8. PubMed ID: 22699110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility.
    Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ
    Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
    Bharmal M; Thomas J
    Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of EQ-5D and 15D in the assessment of health-related quality of life in chronic pain.
    Vartiainen P; Mäntyselkä P; Heiskanen T; Hagelberg N; Mustola S; Forssell H; Kautiainen H; Kalso E
    Pain; 2017 Aug; 158(8):1577-1585. PubMed ID: 28715354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimens.
    Stepanova M; Nader F; Cure S; Bourhis F; Hunt S; Younossi ZM
    Aliment Pharmacol Ther; 2014 Sep; 40(6):676-85. PubMed ID: 25040192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients.
    Zhang F; Yang Y; Huang T; Zhang Y; Zhao L; Li S
    Int J Rheum Dis; 2018 Jun; 21(6):1185-1192. PubMed ID: 27463704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
    Jankowska A; Młyńczak K; Golicki D
    Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.
    Garcia-Gordillo MÁ; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellan-Perpiñan JM; Sanchez-Martinez FI
    Nutr Hosp; 2015 Dec; 32(6):2808-21. PubMed ID: 26667738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.